Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Adaptive Biotechnologies Corp

NASDAQ: ADPT · Life Sciences · 17 alerts · CIK 1478320

Share price
$27.87Close, Nov 16
Market cap
$4.51B
Shares outstanding
161.88MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Adaptive Biotechnologies Corp filings on SEC EDGAR ↗

7:59 PM ET Form 4
Insider Selling

Adaptive Biotechnologies President and COO Julie Rubinstein Sells $1.05M of Stock

Julie Rubinstein, President and COO, sold 35,228 shares of Adaptive Biotechnologies Corp at $28.93 to $31.22 a share (average $29.73) in 4 transactions, worth $1.05M in total between Nov 11, 2026 and Nov 13, 2026. Shares held after the trade: 377,802 (-2.9%).

Value
$1.05M
Shares
35,228
Average price
$29.73
Role
President and COO
Holding change
-2.9%
Trade date
Nov 11, 2026 to Nov 13, 2026
7:56 PM ET Form 4
Insider Selling

Adaptive Biotechnologies Chief Commercial Officer, MRD Susan Bobulsky Sells $60K of Stock

Susan Bobulsky, Chief Commercial Officer, MRD, sold 1,875 shares of Adaptive Biotechnologies Corp at $32.00 a share, worth $60K in total on Nov 11, 2026. Shares held after the trade: 387,475 (-0.5%).

Value
$60K
Shares
1,875
Price
$32.00
Role
Chief Commercial Officer, MRD
Holding change
-0.5%
Trade date
Nov 11, 2026
7:26 PM ET Form 4
Insider Selling

Adaptive Biotechnologies President and COO Julie Rubinstein Sells $709K of Stock

Julie Rubinstein, President and COO, sold 23,762 shares of Adaptive Biotechnologies Corp at $28.87 to $30.58 a share (average $29.82) in 5 transactions, worth $709K in total between Nov 9, 2026 and Nov 10, 2026. Shares held after the trade: 377,802 (-0.5%).

Value
$709K
Shares
23,762
Average price
$29.82
Role
President and COO
Holding change
-0.5%
Trade date
Nov 9, 2026 to Nov 10, 2026
7:24 PM ET Form 4
Insider Selling

Adaptive Biotechnologies President and COO Julie Rubinstein Sells $954K of Stock

Julie Rubinstein, President and COO, sold 35,643 shares of Adaptive Biotechnologies Corp at $25.78 to $27.88 a share (average $26.78) in 7 transactions, worth $954K in total between Nov 4, 2026 and Nov 6, 2026. Shares held after the trade: 377,802 (-0.9%).

Value
$954K
Shares
35,643
Average price
$26.78
Role
President and COO
Holding change
-0.9%
Trade date
Nov 4, 2026 to Nov 6, 2026
7:52 PM ET Form 4
Insider Selling

Adaptive Biotechnologies President and COO Julie Rubinstein Sells $929K of Stock

Julie Rubinstein, President and COO, sold 35,643 shares of Adaptive Biotechnologies Corp at $25.23 to $27.45 a share (average $26.06) in 5 transactions, worth $929K in total between Oct 30, 2026 and Nov 3, 2026. Shares held after the trade: 377,802 (-3.0%).

Value
$929K
Shares
35,643
Average price
$26.06
Role
President and COO
Holding change
-3.0%
Trade date
Oct 30, 2026 to Nov 3, 2026
7:53 PM ET Form 4
Insider Selling

Adaptive Biotechnologies President and COO Julie Rubinstein Sells $992K of Stock

Julie Rubinstein, President and COO, sold 35,443 shares of Adaptive Biotechnologies Corp at $26.58 to $28.44 a share (average $28.00) in 4 transactions, worth $992K in total between Oct 27, 2026 and Oct 29, 2026. Shares held after the trade: 377,802 (-3.0%).

Value
$992K
Shares
35,443
Average price
$28.00
Role
President and COO
Holding change
-3.0%
Trade date
Oct 27, 2026 to Oct 29, 2026
6:53 PM ET Form 4
Insider Selling

Adaptive Biotechnologies President and COO Julie Rubinstein Sells $897K of Stock

Julie Rubinstein, President and COO, sold 35,643 shares of Adaptive Biotechnologies Corp at $24.38 to $26.30 a share (average $25.18) in 6 transactions, worth $897K in total between Oct 22, 2026 and Oct 26, 2026. Shares held after the trade: 377,802 (-0.9%).

Value
$897K
Shares
35,643
Average price
$25.18
Role
President and COO
Holding change
-0.9%
Trade date
Oct 22, 2026 to Oct 26, 2026
6:36 PM ET Form 4
Insider Selling

Adaptive Biotechnologies President and COO Julie Rubinstein Sells $877K of Stock

Julie Rubinstein, President and COO, sold 35,543 shares of Adaptive Biotechnologies Corp at $24.05 to $25.57 a share (average $24.66) in 4 transactions, worth $877K in total between Oct 19, 2026 and Oct 21, 2026. Shares held after the trade: 377,802 (-1.5%).

Value
$877K
Shares
35,543
Average price
$24.66
Role
President and COO
Holding change
-1.5%
Trade date
Oct 19, 2026 to Oct 21, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.